Tim Oldham, PHD

Tim was appointed CEO and MD of AdAlta Ltd in October 2019. Tim has almost 20 years of life sciences business development, alliance management, portfolio and product development, and commercialisation experience in Europe, Asia and Australia, with a particular focus on biologics, cell and gene therapies and pharmaceutical products. Immediately prior to AdAlta, he was Executive Leader of Tijan Ventures, an advisory business with a particular focus on biologics, cell and gene therapies and immunotherapy. Previous roles include CEO and Managing Director of Cell Therapies Pty Ltd, a leading contract manufacturer and distributor cellular therapies in Asia Pacific, President of Asia Pacific for Hospira, Inc., and senior management roles with Mayne Pharma Ltd (EMEA) prior to its acquisition by Hospira. Prior to this, Tim was an engagement manager with McKinsey & Co. He is currently serving as a Director of BioMelbourne Network Inc and Acrux Ltd (AXS:ACR).